|
|
 |
Kevin J. Kinsella, Managing Member
Kevin Kinsella founded Avalon in 1983. He has specialized in the formation, financing and/or development of more than 60 early-stage companies, including: Athena Neurosciences (acquired by Elan Corporation, plc (NYSE: ELN)); Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX); Sequana Therapeutics (merged with Arris to form AXYS Pharmaceuticals... read more
Richard W. Levandov, Managing Member
Richard W. Levandov has over 25 years of experience as an entrepreneur, operating Rich Levandov has over 25 years of experience as an entrepreneur, operator, angel investor and venture capitalist involving a variety of cutting-edge, early-stage technology companies. It was after Mr. Levandov had co-founded Phoenix Technologies... read more
Jay B. Lichter, Ph.D., Managing Member
Jay B. Lichter, Ph.D. is an experienced biotechnology and pharmaceutical business executive with 25 years of experience in management, scientific research, and business development. Throughout his career, Dr. Lichter has applied his exceptional combination of business acumen and deep technical knowledge to creating commercially successful biotech... read more
Stephen L. Tomlin, Managing Member
Steve Tomlin has been an entrepreneur, senior executive and investor in the wireless technology, biotechnology and Internet industries for 20 years. He joined Avalon in 2001 to lead Avalon's wireless technology investment activities. Mr. Tomlin is the Chairman and acting CEO of chumby industries, a Director of E-Band Communications... read more
Braden M. Bohrmann, Managing Member
Brady Bohrmann joined Avalon in 2007 as a Venture Partner. He has over 20 years of experience as a venture capitalist and operating executive in both biotech and information technology. He serves on the boards of directors of Avalon portfolio companies Afraxis, Carolus, Pictela, Twinstrata, Cloudant, Inc. and Cloudkick, and is a board... read more
Douglas J. Downs, Managing Member and Chief Financial Officer
Douglas Downs joined Avalon as Chief Financial Officer in 2007. Mr. Downs has over 20 years of senior financial and operational experience in technology companies ranging from start-ups to large public companies. He has served as a board member and audit committee chair, and as CFO has led multiple public offerings and venture financings... read more
Court R. Turner, Venture Partner
Court R. Turner, J.D. is a Venture Partner. Mr. Turner is also President, CEO and Director of Carolus Therapeutics, COO of Afraxis,Inc., COO and Director of Otonomy, Inc and Director of Zacharon Pharmaceuticals, all Avalon companies. Prior to joining the Avalon team, Mr. Turner spent over a decade of his career within companies... read more
|
|
